CorMedix CRMD Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total selling and marketing expense by Business | ||||||
| Other selling and marketing | $18.26M+33.5% | $15.44M+1.3% | $13.11M-15.3% | $12.68M-20.5% | $13.68M-12.6% | |
| Total research and development by Business | ||||||
| Other research and development | $14.36M+328% | $11.58M+679% | $7.2M+254% | $4.38M+30.8% | $3.35M-28.4% | |
| Total general and administrative expense by Business | ||||||
| Other general and administrative | $43.98M+285% | $35.64M+206% | $24.7M+141% | $11.89M+23.9% | $11.42M+40.8% | |
| Total Revenue by Product | ||||||
| Contract revenue | $12.88M— | $7.37M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CorMedix break its business down?
- CorMedix (CRMD) reports total selling and marketing expense by business across 2 parts — Employee and contracted employee expense and Other selling and marketing. Each is extracted from the segment footnotes and tracked over time.
- Where does CorMedix's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CorMedix's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
